OM vs LUNG

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Oct 22, 2026

OM

36.3
AI Score
VS
LUNG Wins

LUNG

61.2
AI Score

Investment Advisor Scores

OM

36score
Recommendation
AVOID NEW MONEY

LUNG

61score
Recommendation
BUY

AI Analyst Insights

Detailed Metrics Comparison

Metric OM LUNG Winner
Forward P/E 0 28.3286 Tie
PEG Ratio 0 0 Tie
Revenue Growth 0.7% -4.6% OM
Earnings Growth 0.0% 0.0% Tie
Tradestie Score 36.3/100 61.2/100 LUNG
Profit Margin -63.1% -55.0% LUNG
Beta 1.00 1.00 Tie
AI Recommendation AVOID NEW MONEY BUY LUNG

Relative Price Performance (Last 90 Days)

OM 1M: +35.0% · 3M: +3.2% LUNG 1M: -6.0% · 3M: +60.7%

Current Technical Phase

OM

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 58

RSI (14): 58.3 · Price: $4.17

LUNG

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 50

RSI (14): 50.1 · Price: $1.88

Fundamentals Snapshot

Metric OM LUNG
Market Cap — —
Forward P/E -1.8 -2.0
Trailing P/E — —
Revenue (TTM) — —
Revenue Growth 0.0% 0.0%
Gross Margin 0.4% 0.8%
Operating Margin -0.5% -0.4%
EPS -4.00 -1.15
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, LUNG is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.